HEADER VIRAL PROTEIN/IMMUNE SYSTEM 01-NOV-22 8HC8 TITLE SARS-COV-2 OMICRON BA.1 SPIKE TRIMER (6P) IN COMPLEX WITH YB13-292 TITLE 2 FAB, FOCUSED REFINEMENT OF FAB REGION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEAVY CHAIN OF YB13-292 FAB; COMPND 7 CHAIN: H; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: LIGHT CHAIN OF YB13-292 FAB; COMPND 11 CHAIN: L; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS SPIKE PROTEIN, RBD, ANTIBODY, FAB, VIRAL PROTEIN, VIRAL PROTEIN- KEYWDS 2 IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR B.LIU,X.GAO,Q.CHEN,Z.LI,M.SU,J.HE,X.XIONG REVDAT 2 03-MAY-23 8HC8 1 JRNL REVDAT 1 25-JAN-23 8HC8 0 JRNL AUTH H.YU,B.LIU,Y.ZHANG,X.GAO,Q.WANG,H.XIANG,X.PENG,C.XIE,Y.WANG, JRNL AUTH 2 P.HU,J.SHI,Q.SHI,P.ZHENG,C.FENG,G.TANG,X.LIU,L.GUO,X.LIN, JRNL AUTH 3 J.LI,C.LIU,Y.HUANG,N.YANG,Q.CHEN,Z.LI,M.SU,Q.YAN,R.PEI, JRNL AUTH 4 X.CHEN,L.LIU,F.HU,D.LIANG,B.KE,C.KE,F.LI,J.HE,M.WANG,L.CHEN, JRNL AUTH 5 X.XIONG,X.TANG JRNL TITL SOMATICALLY HYPERMUTATED ANTIBODIES ISOLATED FROM SARS-COV-2 JRNL TITL 2 DELTA INFECTED PATIENTS CROSS-NEUTRALIZE HETEROLOGOUS JRNL TITL 3 VARIANTS. JRNL REF NAT COMMUN V. 14 1058 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36828833 JRNL DOI 10.1038/S41467-023-36761-0 REMARK 2 REMARK 2 RESOLUTION. 3.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : FOURIER SPACE REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.950 REMARK 3 NUMBER OF PARTICLES : 210698 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8HC8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1300033117. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 OMICRON BA.1 SPIKE REMARK 245 TRIMER WITH IN COMPLEX WITH REMARK 245 YB13-292 FAB, FOCUSED REMARK 245 REFINEMENT OF FAB REGION; SARS- REMARK 245 COV-2 OMICRON BA.1 SPIKE REMARK 245 PROTEIN; YB13-292 FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TALOS ARCTICA REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU H 1 REMARK 465 LYS H 235 REMARK 465 SER H 236 REMARK 465 CYS H 237 REMARK 465 ASP H 238 REMARK 465 LYS L 79 REMARK 465 ILE L 80 REMARK 465 SER L 81 REMARK 465 ARG L 82 REMARK 465 VAL L 83 REMARK 465 GLU L 84 REMARK 465 ALA L 85 REMARK 465 GLU L 86 REMARK 465 ASP L 87 REMARK 465 VAL L 88 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU L 110 CG CD OE1 OE2 REMARK 470 LYS L 112 CG CD CE NZ REMARK 470 ARG L 147 CG CD NE CZ NH1 NH2 REMARK 470 LYS L 150 CG CD CE NZ REMARK 470 LYS L 174 CG CD CE NZ REMARK 470 LYS L 188 CG CD CE NZ REMARK 470 LYS L 195 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS C 378 52.40 39.74 REMARK 500 LYS C 386 52.93 -92.90 REMARK 500 ASP C 442 52.72 -92.11 REMARK 500 SER H 153 168.37 63.98 REMARK 500 ARG L 31 -126.74 58.85 REMARK 500 ASN L 143 77.49 43.09 REMARK 500 PRO L 146 -174.83 -66.27 REMARK 500 ARG L 147 63.68 63.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-34655 RELATED DB: EMDB REMARK 900 SARS-COV-2 OMICRON BA.1 SPIKE TRIMER IN COMPLEX WITH YB13-292 FAB, REMARK 900 FOCUSED REFINEMENT OF FAB REGION DBREF 8HC8 C 332 517 UNP P0DTC2 SPIKE_SARS2 332 517 DBREF 8HC8 H 1 238 PDB 8HC8 8HC8 1 238 DBREF 8HC8 L 1 219 PDB 8HC8 8HC8 1 219 SEQADV 8HC8 ASP C 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 8HC8 LEU C 371 UNP P0DTC2 SER 371 VARIANT SEQADV 8HC8 PRO C 373 UNP P0DTC2 SER 373 VARIANT SEQADV 8HC8 PHE C 375 UNP P0DTC2 SER 375 VARIANT SEQADV 8HC8 ASN C 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 8HC8 LYS C 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 8HC8 SER C 446 UNP P0DTC2 GLY 446 VARIANT SEQADV 8HC8 ASN C 477 UNP P0DTC2 SER 477 VARIANT SEQADV 8HC8 LYS C 478 UNP P0DTC2 THR 478 VARIANT SEQADV 8HC8 ALA C 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 8HC8 ARG C 493 UNP P0DTC2 GLN 493 VARIANT SEQADV 8HC8 SER C 496 UNP P0DTC2 GLY 496 VARIANT SEQADV 8HC8 ARG C 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 8HC8 TYR C 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 8HC8 HIS C 505 UNP P0DTC2 TYR 505 VARIANT SEQRES 1 C 186 ILE THR ASN LEU CYS PRO PHE ASP GLU VAL PHE ASN ALA SEQRES 2 C 186 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 3 C 186 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 4 C 186 LEU ALA PRO PHE PHE THR PHE LYS CYS TYR GLY VAL SER SEQRES 5 C 186 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 6 C 186 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 7 C 186 ILE ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN SEQRES 8 C 186 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 9 C 186 TRP ASN SER ASN LYS LEU ASP SER LYS VAL SER GLY ASN SEQRES 10 C 186 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 11 C 186 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 12 C 186 ALA GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY PHE ASN SEQRES 13 C 186 CYS TYR PHE PRO LEU ARG SER TYR SER PHE ARG PRO THR SEQRES 14 C 186 TYR GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 15 C 186 SER PHE GLU LEU SEQRES 1 H 238 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 H 238 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 238 PHE SER PHE ILE THR TYR ASN MET ASN TRP VAL ARG GLN SEQRES 4 H 238 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER SER ILE SER SEQRES 5 H 238 SER ASN ILE LEU SER SER THR SER TYR ILE TYR TYR ALA SEQRES 6 H 238 ASP SER VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASP SEQRES 7 H 238 ALA ALA ASN SER LEU PHE LEU GLN MET ASN SER LEU ARG SEQRES 8 H 238 VAL GLU ASP THR ALA GLN TYR TYR CYS ALA ARG THR ARG SEQRES 9 H 238 SER ARG SER VAL ARG ASN CYS THR SER ALA THR CYS PRO SEQRES 10 H 238 VAL ASP ALA PHE ASP LEU TRP GLY GLN GLY THR MET VAL SEQRES 11 H 238 ILE VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE SEQRES 12 H 238 PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR SEQRES 13 H 238 ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU SEQRES 14 H 238 PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER SEQRES 15 H 238 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY SEQRES 16 H 238 LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SEQRES 17 H 238 SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS SEQRES 18 H 238 LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO SEQRES 19 H 238 LYS SER CYS ASP SEQRES 1 L 219 ASP ILE VAL LEU THR GLN SER PRO LEU SER LEU PRO VAL SEQRES 2 L 219 THR PRO GLY GLU PRO ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 219 GLN SER LEU LEU ARG SER ASN GLY TYR ASN TYR LEU ASP SEQRES 4 L 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO HIS LEU LEU SEQRES 5 L 219 ILE TYR LEU GLY SER ASN ARG ALA SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP VAL GLY VAL TYR SEQRES 8 L 219 TYR CYS MET GLN ALA LEU GLN THR PRO TYR THR PHE GLY SEQRES 9 L 219 GLN GLY THR ASN LEU GLU ILE LYS ARG THR VAL ALA ALA SEQRES 10 L 219 PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU SEQRES 11 L 219 LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP SEQRES 13 L 219 ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR SEQRES 14 L 219 GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER SEQRES 15 L 219 THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS SEQRES 16 L 219 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 L 219 PRO VAL THR LYS SER PHE ASN ARG GLY GLU CYS HET NAG C 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG C8 H15 N O6 HELIX 1 AA1 TYR C 365 ASN C 370 5 6 HELIX 2 AA2 GLU C 406 ILE C 410 5 5 HELIX 3 AA3 GLY C 416 ASN C 422 1 7 HELIX 4 AA4 GLY C 502 GLN C 506 5 5 HELIX 5 AA5 ASP H 78 ALA H 80 5 3 HELIX 6 AA6 SER H 177 ALA H 179 5 3 HELIX 7 AA7 SER H 208 LEU H 210 5 3 HELIX 8 AA8 SER L 126 LYS L 131 1 6 HELIX 9 AA9 LYS L 188 LYS L 193 1 6 SHEET 1 AA1 4 LYS C 356 ILE C 358 0 SHEET 2 AA1 4 VAL C 395 ILE C 402 -1 O ALA C 397 N LYS C 356 SHEET 3 AA1 4 TYR C 508 PHE C 515 -1 O TYR C 508 N ILE C 402 SHEET 4 AA1 4 GLY C 431 ASN C 437 -1 N ILE C 434 O VAL C 511 SHEET 1 AA2 2 LEU C 452 ARG C 454 0 SHEET 2 AA2 2 LEU C 492 SER C 494 -1 O ARG C 493 N TYR C 453 SHEET 1 AA3 2 TYR C 473 GLN C 474 0 SHEET 2 AA3 2 CYS C 488 TYR C 489 -1 O TYR C 489 N TYR C 473 SHEET 1 AA4 4 LEU H 4 SER H 7 0 SHEET 2 AA4 4 LEU H 20 ALA H 24 -1 O ALA H 23 N VAL H 5 SHEET 3 AA4 4 SER H 82 GLN H 86 -1 O LEU H 83 N CYS H 22 SHEET 4 AA4 4 THR H 73 ASP H 77 -1 N ASP H 77 O SER H 82 SHEET 1 AA5 6 LEU H 11 VAL H 12 0 SHEET 2 AA5 6 THR H 128 VAL H 132 1 O ILE H 131 N VAL H 12 SHEET 3 AA5 6 ALA H 96 ARG H 102 -1 N TYR H 98 O THR H 128 SHEET 4 AA5 6 MET H 34 GLN H 39 -1 N VAL H 37 O TYR H 99 SHEET 5 AA5 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AA5 6 ILE H 62 TYR H 64 -1 O TYR H 63 N SER H 50 SHEET 1 AA6 4 LEU H 11 VAL H 12 0 SHEET 2 AA6 4 THR H 128 VAL H 132 1 O ILE H 131 N VAL H 12 SHEET 3 AA6 4 ALA H 96 ARG H 102 -1 N TYR H 98 O THR H 128 SHEET 4 AA6 4 LEU H 123 TRP H 124 -1 O LEU H 123 N ARG H 102 SHEET 1 AA7 4 SER H 141 PRO H 144 0 SHEET 2 AA7 4 THR H 156 TYR H 166 -1 O LEU H 162 N PHE H 143 SHEET 3 AA7 4 TYR H 197 PRO H 206 -1 O SER H 201 N CYS H 161 SHEET 4 AA7 4 VAL H 184 THR H 186 -1 N HIS H 185 O VAL H 202 SHEET 1 AA8 4 SER H 141 PRO H 144 0 SHEET 2 AA8 4 THR H 156 TYR H 166 -1 O LEU H 162 N PHE H 143 SHEET 3 AA8 4 TYR H 197 PRO H 206 -1 O SER H 201 N CYS H 161 SHEET 4 AA8 4 VAL H 190 LEU H 191 -1 N VAL H 190 O SER H 198 SHEET 1 AA9 3 THR H 172 TRP H 175 0 SHEET 2 AA9 3 ILE H 216 HIS H 221 -1 O ASN H 220 N THR H 172 SHEET 3 AA9 3 THR H 226 LYS H 231 -1 O LYS H 230 N CYS H 217 SHEET 1 AB1 4 THR L 5 GLN L 6 0 SHEET 2 AB1 4 SER L 22 ARG L 24 -1 O ARG L 24 N THR L 5 SHEET 3 AB1 4 ASP L 75 THR L 77 -1 O PHE L 76 N CYS L 23 SHEET 4 AB1 4 SER L 70 SER L 72 -1 N SER L 70 O THR L 77 SHEET 1 AB2 2 PRO L 12 VAL L 13 0 SHEET 2 AB2 2 GLU L 110 ILE L 111 1 O GLU L 110 N VAL L 13 SHEET 1 AB3 3 HIS L 50 ILE L 53 0 SHEET 2 AB3 3 TRP L 40 GLN L 43 -1 N TRP L 40 O ILE L 53 SHEET 3 AB3 3 VAL L 90 CYS L 93 -1 O TYR L 92 N TYR L 41 SHEET 1 AB4 4 PHE L 121 PHE L 123 0 SHEET 2 AB4 4 THR L 134 ASN L 142 -1 O LEU L 140 N PHE L 121 SHEET 3 AB4 4 SER L 179 SER L 187 -1 O LEU L 186 N ALA L 135 SHEET 4 AB4 4 SER L 164 VAL L 168 -1 N GLN L 165 O THR L 183 SHEET 1 AB5 3 GLN L 152 VAL L 155 0 SHEET 2 AB5 3 VAL L 196 VAL L 201 -1 O ALA L 198 N LYS L 154 SHEET 3 AB5 3 VAL L 210 ASN L 215 -1 O PHE L 214 N TYR L 197 SSBOND 1 CYS C 336 CYS C 361 1555 1555 2.03 SSBOND 2 CYS C 379 CYS C 432 1555 1555 2.04 SSBOND 3 CYS C 480 CYS C 488 1555 1555 2.03 SSBOND 4 CYS H 22 CYS H 100 1555 1555 2.03 SSBOND 5 CYS H 111 CYS H 116 1555 1555 2.03 SSBOND 6 CYS H 161 CYS H 217 1555 1555 2.03 SSBOND 7 CYS L 23 CYS L 93 1555 1555 2.03 SSBOND 8 CYS L 139 CYS L 199 1555 1555 2.04 LINK ND2 ASN C 343 C1 NAG C 601 1555 1555 1.44 CISPEP 1 PHE H 167 PRO H 168 0 3.39 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000